Summary 24 25
The advances in molecular biology of the last decades have dramatically improved the field of 26 diagnostic bacteriology. In particular PCR-based technologies have impacted the diagnosis of 27 infections caused by obligate intracellular bacteria such as pathogens from the Chlamydiacae 28 family. Here, we describe a real-time PCR-based method using the Taqman technology for the 29 diagnosis of Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia abortus infection. The 30 method presented here can be applied to various clinical samples and can be adapted on opened 31 molecular diagnostic platforms. 32
Introduction 36
Chlamydiacae are obligate intracellular bacteria, among which several species are pathogenic 37 towards humans and can cause a broad range of diseases. Chlamydia trachomatis is involved in 38 urogenital infection as well as ocular, joint and oropharyngeal infections. Chlamydia 39 pneumoniae and Chlamydia psittaci are primarily associated with community-acquired 40 pneumonia (CAP). C. pneumoniae have been essentially associated with infections in humans [1] 41 but some studies suggest an association with other mammals such as koalas [2] [3] [4] [5] [6] [7] [8] . C. 42 pneumoniae might also be a causative agent of an asthma-like syndrome in children [9] . C. 43 psittaci is the etiologic agent of a respiratory zoonosis transmitted by birds, in particular parrots 44 and parakeets, but also chicken from the food industries as well as feral pigeons [2] . C. abortus is 45 genetically closely related to C. psittaci but displays a distinct animal and tissue tropism as it can 46 colonize the placenta of cows, goats, cattles, pigs and horses, which can lead to abortion. C. 47 abortus can be transmitted to humans, for instance through the exposure to infected animal 48 abortive tissues, with the same outcome for pregnant women [2] . 49
The diagnosis of infections due to intracellular bacteria has been dramatically improved by PCR-50 based methods developed in the last decades. This is particularly true for the diagnosis of C. 51 trachomatis, for which several commercial systems have been developed. The laboratory of 52 
Sample processing 113
In clinical practice, the detection of C. pneumoniae, C. psittaci and C. abortus can be achieved 114 from a broad range of samples (Table 2) . Depending on the nature of the sample (liquid, viscous 115 or solid) a specific processing will be required either to concentrate (liquid samples) or to 116 homogenize (viscous or solid samples) the specimen. 117 118 1. Introduce the lab request into the laboratory information system (LIS) to generate the 119 barcode labels necessary to manage tubes during the analytic process (See Note 5). 120 2. For each sample, label three screw cap tubes (2ml) with the barcode as follows: one 121 "native" tube, one "native-aliquot" tube and one "DNA tube". 122
3. Under the laminar flow dedicated for molecular diagnostics in the "specimen-receiving 123 laboratory," distribute the sample into the native-aliquot tube and the native tube. The 124 native tube will be frozen at -80°C and kept as backup in case of need. If necessary 125 several native tubes can be stored; a suggestion for biopsies would be to store both the 126 native samples and the processed samples in distinct tubes. The aliquot-native tube 127 together with the DNA tube will be transported to the molecular diagnostic laboratory To avoid the dilution of the specimen, which could negatively impact the sensitivity of the PCR, 288 do not add too much solution for the crushing of the sample. 289 negative for PCR2 can be considered as positive for C. psittaci for respiratory specimens and 320 positive for C. abortus for genital specimens. 321 322
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